Mode
Text Size
Log in / Sign up
Phase 4 N=10 Randomized Single-blind Prevention

Influence of Anesthetic Technique on Acute and Chronic Neuropathic Pain

Acute Pain · Chronic Pain · Hernia · Anesthesia, Intravenous · Anesthesia, Intratracheal

Enrolled (actual)
10
Serious AEs
0.0%
Results posted
Dec 2025
Primary outcome: Primary: Pain Score, Chronic — 1.7; 1.5; 0; .8 score on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Propofol (Drug); Sevoflurane (Drug); Remifentanil (Drug); Ketamine (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
Male
Sponsor
VA Pittsburgh Healthcare System
Primary completion
Jun 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain Score, Chronic
1.7; 1.5; 0; .8; 0; 0
SECONDARY
Pain Score, Acute
4.6; 9.0; 3.0

Summary

Research suggests that the type of anesthesia used for surgery may affect intraoperative stress hormone levels. There is also data to support that an increased level of stress hormones leads to increased pain after surgery. The primary aim of this study is to determine the effect of anesthesia type on long term pain after hernia surgery. In this study, patients undergoing inguinal hernia repair will be randomized to an anesthetic group, either Total Intravenous Anesthesia (TIVA) maintained with propofol or Balanced Inhaled Anesthesia (BIA) maintained with sevoflurane. This will allow us to look at any differences in short and long-term pain after hernia repair depending on type of anesthesia received.

Eligibility Criteria

Inclusion Criteria

  • All male patients undergoing herniorrhaphy surgery that requires general anesthesia.

Exclusion Criteria

  • Subjects unable to communicate directly with the investigators, due to being non-English speaking, loss of hearing, or incompetence.
  • A history of malignant hyperthermia, pseudocholinesterase deficiency, or other disease that prevents anesthetic randomization.
  • Pain-related disorders such as fibromyalgia or other chronic pain syndromes.
  • Emergency surgery.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02527083). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search